The Myeloproliferative Neoplasia (MPN) Panel is a comprehensive diagnostic test designed to identify genetic mutations associated with myeloproliferative disorders, which are a group of diseases that cause blood cells to grow abnormally in the bone marrow. This panel specifically targets mutations in the BCR-ABL1, JAK2, CALR, and MPL genes, which are crucial for diagnosing and managing conditions such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Performed at DNA Labs UAE, a leading facility in genetic testing, the MPN Panel leverages qualitative techniques (QLT) to accurately detect the presence of these mutations. The inclusion of the BCR-ABL1 gene in the panel is particularly important for distinguishing between chronic myeloid leukemia and other MPN disorders, as it is the hallmark mutation of chronic myeloid leukemia.
The cost of the MPN Panel at DNA Labs UAE is 4200 AED. This investment covers the comprehensive analysis required to identify the genetic underpinnings of myeloproliferative neoplasms, which is essential for guiding treatment decisions and predicting patient outcomes. Given the complexity and the detailed genetic insights provided by this panel, it represents a critical step towards personalized medicine in the management of myeloproliferative disorders.
The IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the IGHM gene. These mutations are responsible for a rare immunodeficiency disorder known as Agammaglobulinemia Type 1, which is inherited in an autosomal recessive manner. This condition is characterized by an extremely low level of immunoglobulins (antibodies) in the blood, leading to a heightened susceptibility to infections.
The test is crucial for early diagnosis and management of the condition, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test offers a comprehensive analysis of the IGHM gene to identify specific genetic alterations.
The cost of the IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed examination and analysis necessary to pinpoint the genetic underpinnings of this immune disorder, providing invaluable information for affected individuals and their families.
The "SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the SDHD gene. Mutations in this gene are known to be associated with an increased risk of developing paraganglioma, a rare type of tumor that can occur in various parts of the body, and gastric stromal sarcoma, a form of cancer affecting the stomach's connective tissue. The test is particularly important for individuals with a family history of these conditions, as it can provide crucial information for early detection and management. By analyzing the genetic makeup, the test helps in understanding the genetic predisposition of an individual towards these conditions, enabling personalized treatment plans and preventive measures. The cost of the test is 4400 AED, making it a valuable investment for those seeking to assess their genetic risk for these specific types of cancer. Conducted at DNA Labs UAE, this genetic test is a step forward in the realm of personalized medicine, offering insights that could significantly impact an individual's healthcare strategy.
The "SDHD Gene Paragangliomas Type 1 With or Without Deafness Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SDHD gene, which are linked to the development of paragangliomas type 1. Paragangliomas are rare, often hereditary tumors that can occur in various parts of the body, including the head and neck. Some individuals with mutations in the SDHD gene may also experience hearing loss, either as a part of the condition or independently. This genetic test is crucial for individuals with a family history of paragangliomas or early onset deafness, as it can provide vital information for managing their health. The test is priced at 4400 AED and is conducted with the highest standards of accuracy and confidentiality at DNA Labs UAE.
The "SDHB Gene Paragangliomas Type 4 Genetic Test" is a specialized diagnostic tool used to detect mutations in the SDHB gene, which are associated with the development of Paragangliomas Type 4. Paragangliomas are rare, often hereditary tumors that can develop in various parts of the body, including the adrenal gland, resulting in a condition known as pheochromocytoma when the tumor is adrenal-based. The SDHB gene plays a crucial role in the mitochondrial respiratory chain, and mutations in this gene can lead to the formation of these tumors. Identifying mutations in the SDHB gene is essential for the accurate diagnosis, management, and familial risk assessment of Paragangliomas Type 4.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is set at 4400 AED. This test is particularly important for individuals with a family history of paragangliomas or related conditions, as it can help in the early detection and prevention of tumor development. By choosing DNA Labs UAE for this test, patients can expect state-of-the-art facilities, highly qualified genetic counselors, and accurate results, contributing to better health outcomes and personalized treatment plans.
The SDHA Gene Paragangliomas Type 5 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SDHA gene, which are linked to the development of Paragangliomas Type 5. Paragangliomas are rare, often hereditary tumors that can occur in various parts of the body, including the head, neck, and abdomen. These tumors are associated with the nervous system and, depending on their location, can significantly impact bodily functions and overall health.
This genetic test is crucial for individuals with a family history of paragangliomas or those who exhibit symptoms associated with these tumors. Early detection through genetic testing allows for timely intervention and management of the condition, potentially reducing the risk of complications.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the detailed, personalized insights it provides. By opting for this test at DNA Labs UAE, patients can expect a thorough evaluation, with results that can guide clinical decisions, inform treatment strategies, and offer a clearer understanding of their genetic risk for developing Paragangliomas Type 5.
The PDGFRA Gene PDGFRA Selective Sequencing of Exons 12, 14, and 18 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations within specific exons of the Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) gene. This gene plays a crucial role in cell growth, development, and division. Mutations in exons 12, 14, and 18 of the PDGFRA gene have been linked to various medical conditions, including certain types of cancers and gastrointestinal stromal tumors (GISTs). By targeting these specific exons, the test provides critical information that can guide treatment decisions and prognosis.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves the extraction of DNA from a patient's blood sample, followed by selective sequencing of the PDGFRA gene's exons 12, 14, and 18. The process is meticulous and requires state-of-the-art technology to accurately detect any genetic abnormalities that may be present.
The cost of the PDGFRA Gene PDGFRA Selective Sequencing of Exons 12, 14, and 18 Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced technology and expertise required to perform it. For patients facing conditions potentially linked to PDGFRA gene mutations, this test offers a valuable tool for achieving a precise diagnosis and tailoring a treatment strategy that is specifically suited to their genetic profile.
The STK11 gene Peutz-Jeghers syndrome genetic test is a specialized diagnostic procedure aimed at detecting mutations in the STK11 gene, which are indicative of Peutz-Jeghers syndrome (PJS). PJS is a rare genetic condition characterized by the development of distinctive pigmented spots on the skin and a predisposition to polyps in the gastrointestinal tract, along with an increased risk for various types of cancer. The test is conducted to confirm a diagnosis of PJS, assess the risk of associated cancers, and guide management and surveillance strategies for individuals with the syndrome or their at-risk relatives.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA, extracted from a blood sample, to look for mutations in the STK11 gene that are known to cause Peutz-Jeghers syndrome. This comprehensive analysis provides crucial information for affected individuals and their families regarding the management of the condition and the assessment of cancer risk.
The cost of the STK11 gene Peutz-Jeghers syndrome genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the expertise required to accurately interpret the results, and the significant value it offers in terms of personalized medical care and genetic counseling for patients and their families.
The SDHD Gene Pheochromocytoma Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the SDHD gene, which are linked to the development of Pheochromocytoma Type 1. Pheochromocytomas are rare, usually benign tumors that originate from the chromaffin cells of the adrenal gland, leading to excessive production of adrenaline and noradrenaline, which can cause high blood pressure, heart palpitations, and a series of other symptoms. The SDHD gene plays a crucial role in the mitochondrial complex II, involved in the electron transport chain, and mutations in this gene can predispose individuals to developing these tumors.
This genetic test is pivotal for individuals with a family history of pheochromocytoma or those exhibiting symptoms suggestive of the condition, as it can confirm the genetic basis of the disease and facilitate early intervention and management. By identifying mutations in the SDHD gene, healthcare providers can offer tailored surveillance and treatment strategies, significantly improving patient outcomes.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SDHD gene. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test is performed under stringent quality controls to ensure accurate, reliable results. This test represents a critical tool in the diagnosis and management of Pheochromocytoma Type 1, offering at-risk individuals a means to take proactive steps in managing their health.
The "SDHB Gene Pheochromocytoma Type 2 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the SDHB gene, which are linked to the development of Pheochromocytoma Type 2, a rare tumor of the adrenal gland. This condition can significantly impact blood pressure and heart rate, often leading to severe cardiovascular issues. The test is particularly crucial for individuals with a family history of the disease or those presenting symptoms, as early detection can lead to better management and treatment outcomes. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test costs 4400 AED. It involves analyzing the patient's DNA sample to pinpoint any genetic anomalies in the SDHB gene, thereby helping in the accurate diagnosis and guiding the appropriate clinical management for patients.
